Loading data
NKTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 90.43 m USD | 96.74 m USD | 96.77 m USD | 90.9 m USD | 63.41 m USD |
| Operating profit | -122 m USD | -128.19 m USD | -131.65 m USD | -118.96 m USD | -86.43 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -104.08 m USD | -108.79 m USD | -117.5 m USD | -113.84 m USD | -86.08 m USD |
| Basic earnings per share | -1.41 USD/share | -1.6 USD/share | -2.4 USD/share | -2.61 USD/share | -2.62 USD/share |
| Diluted earnings per share | -1.41 USD/share | -1.6 USD/share | -2.4 USD/share | -2.61 USD/share | -2.62 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.